LADENBURG THALMANN FINANCIAL SERVICES INC. - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 91 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$5,000
-28.6%
788
-54.7%
0.00%
Q3 2019$7,000
-30.0%
1,739
-14.9%
0.00%
Q2 2019$10,0000.0%2,043
+64.0%
0.00%
Q1 2019$10,000
+42.9%
1,246
-4.7%
0.00%
Q4 2018$7,000
+600.0%
1,307
+2115.3%
0.00%
Q2 2018$1,0000.0%590.0%0.00%
Q1 2018$1,0000.0%590.0%0.00%
Q4 2017$1,0000.0%590.0%0.00%
Q3 2017$1,0000.0%590.0%0.00%
Q2 2017$1,0000.0%590.0%0.00%
Q1 2017$1,0000.0%590.0%0.00%
Q4 2016$1,0000.0%590.0%0.00%
Q3 2016$1,000590.0%0.00%
Q2 2016$0
-100.0%
590.0%0.00%
Q1 2016$1,000
-50.0%
59
-53.2%
0.00%
Q4 2015$2,0001260.00%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$1,471,0001.42%
Orchard Capital Management, LLC 251,826$80,0000.03%
GSA CAPITAL PARTNERS LLP 486,568$154,0000.02%
Icon Wealth Advisors, LLC 400,132$1270.02%
ACADIAN ASSET MANAGEMENT LLC 7,483,053$2,365,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 2,042,816$646,0000.01%
WIPFLI FINANCIAL ADVISORS LLC, 200,000$63,0000.00%
WEALTH EFFECTS LLC 18,316$6,0000.00%
James J. Burns & Company, LLC 25,142$8,0000.00%
Bayesian Capital Management, LP 68,600$22,0000.00%
View complete list of AKEBIA THERAPEUTICS INC shareholders